Quick Answer
Advanced Biomed Inc. reported R&D Expense of $909.8 thousand for fiscal year 2025.
Advanced Biomed Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $909.8K | +3.4% |
| 2024 | $880.2K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $186.3K | -12.3% | -21.0% |
| September 30, 2025 | $236.0K | +29.9% | -5.8% |
| March 31, 2025 | $250.5K | -20.1% | +17.9% |
| December 31, 2024 | $212.4K | +12.7% | +16.9% |
| September 30, 2024 | $181.7K | — | -42.0% |
| March 31, 2024 | $313.5K | — | +66.4% |
| December 31, 2023 | $188.4K | — | — |
- Advanced Biomed Inc. showed an increase of +3.4% in R&D Expense compared to the prior fiscal year.
- Over the 2024–2025 period, Advanced Biomed Inc.’s r&d expense has grown by 3.4% (from $880.2 thousand to $909.8 thousand).
- The most recent figure is from Advanced Biomed Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: